163 related articles for article (PubMed ID: 32469689)
1. Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Peñaranda-Henao M; Reyes-Guanes J; Muñoz-Ortiz J; Gutiérrez NM; De-La-Torre A
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1366-1369. PubMed ID: 32469689
[No Abstract] [Full Text] [Related]
2. Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Gonul S; Bakbak B
Ocul Immunol Inflamm; 2022 Jan; 30(1):244-245. PubMed ID: 32946301
[TBL] [Abstract][Full Text] [Related]
3. Reply: Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Muñoz-Ortiz J; Reyes-Guanes J; de-la-Torre A
Ocul Immunol Inflamm; 2022 Feb; 30(2):520-521. PubMed ID: 32976052
[No Abstract] [Full Text] [Related]
4. Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.
Zhou AX; Messenger WB; Sargent S; Ambati BK
Int Ophthalmol; 2016 Aug; 36(4):493-8. PubMed ID: 26577588
[TBL] [Abstract][Full Text] [Related]
5. Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: A case report.
Den Beste KA; Okeke C
Medicine (Baltimore); 2017 Oct; 96(43):e7936. PubMed ID: 29068979
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital.
Haripriya A; Chang DF; Namburar S; Smita A; Ravindran RD
Ophthalmology; 2016 Feb; 123(2):302-308. PubMed ID: 26522705
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan.
Matsuura K; Miyoshi T; Suto C; Akura J; Inoue Y
J Cataract Refract Surg; 2013 Nov; 39(11):1702-6. PubMed ID: 24054967
[TBL] [Abstract][Full Text] [Related]
8. Topiramate-induced bilateral anterior uveitis associated with hypopyon formation.
Jabbarpoor Bonyadi MH; Soheilian R; Soheilian M
Ocul Immunol Inflamm; 2011 Feb; 19(1):86-8. PubMed ID: 21034312
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
Bowen RC; Zhou AX; Bondalapati S; Lawyer TW; Snow KB; Evans PR; Bardsley T; McFarland M; Kliethermes M; Shi D; Mamalis CA; Greene T; Rudnisky CJ; Ambati BK
Br J Ophthalmol; 2018 Sep; 102(9):1268-1276. PubMed ID: 29326317
[TBL] [Abstract][Full Text] [Related]
10. Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India.
Rathi VM; Sharma S; Das T; Khanna RC
Indian J Ophthalmol; 2020 May; 68(5):819-824. PubMed ID: 32317453
[TBL] [Abstract][Full Text] [Related]
11. Safety of intracameral moxifloxacin in the pediatric population: an equivalence study.
Khalili S; Imtirat A; Williams S; Ali A; Tehrani N; Mireskandari K
J Cataract Refract Surg; 2020 Feb; 46(2):228-234. PubMed ID: 32126036
[TBL] [Abstract][Full Text] [Related]
12. Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries.
Haripriya A; Chang DF; Ravindran RD
Ophthalmology; 2017 Jun; 124(6):768-775. PubMed ID: 28214101
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of intracameral moxifloxacin.
Matsuura K
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2335-6. PubMed ID: 26047536
[No Abstract] [Full Text] [Related]
14. Circumferential Ciliary Body Cysts Presenting as Acute Pigment Dispersion and Ocular Hypertension.
Sarıgül Sezenöz A; Güngör SG; Kıratlı H; Akman A
Ocul Immunol Inflamm; 2018; 26(8):1261-1263. PubMed ID: 28914584
[TBL] [Abstract][Full Text] [Related]
15. Bilateral acute iris transillumination syndrome. A case report.
Plaza-Ramos P; Heras-Mulero H; Fanlo P; Zubicoa A
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):447-450. PubMed ID: 29398234
[TBL] [Abstract][Full Text] [Related]
16. Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens.
Matsuura K; Suto C; Akura J; Inoue Y
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):81-7. PubMed ID: 22752223
[TBL] [Abstract][Full Text] [Related]
17. Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report.
Rivera-Valdivia N; Arteaga-Rivera K; Reyes-Guanes J; Neira-Segura N; de-la-Torre A
J Med Case Rep; 2021 Sep; 15(1):462. PubMed ID: 34537056
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.
Lane SS; Osher RH; Masket S; Belani S
J Cataract Refract Surg; 2008 Sep; 34(9):1451-9. PubMed ID: 18721703
[TBL] [Abstract][Full Text] [Related]
19. Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India.
Shenoy P; Goh EJH; Kashikar R; Kohli GM; Sachdeva M; Naman V; Sood D; Bhatia P; Sen P; Agrawal R; Sen A
Int Ophthalmol; 2021 Aug; 41(8):2729-2736. PubMed ID: 33821388
[TBL] [Abstract][Full Text] [Related]
20. Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1.
Liaboe C; Samuelson TW
J Cataract Refract Surg; 2022 Jan; 48(1):125. PubMed ID: 34929712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
